HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Schizandrin A ameliorates cognitive functions via modulating microglial polarisation in Alzheimer's disease mice.

AbstractCONTEXT:
Schizandrin A (Sch A) is a major phytochemical from Schisandra chinensis (Turcz.) Baill. (Schisandraceae), which exerts a neuroprotective effect in Alzheimer's disease (AD).
OBJECTIVE:
To investigate the mechanism of Sch A in AD.
MATERIALS AND METHODS:
AD group: APP/PS1 transgenic mice served as AD models; AD + SCH group: APP/PS1 received 2 mg/kg Sch A by intragastric administration; WT: C57BL/6 mice were used as control. For in vitro assay, mouse microglial BV2 cells were treated with 0.5 µg/mL lipopolysaccharide or combined with 10 μmol/L Sch A for 24 h. The cognitive function and apoptosis in the mice was estimated. Microglial polarisation in the mice and cells was analysed.
RESULTS:
Sch A treatment effectively improved spatial learning and memory ability and suppressed apoptosis in the brain tissues of APP/PS1 mice. APP/PS1 mice exhibited an increase in the levels of Aβ1-42 (2367.9 ± 431.1 pg/mg) and Aβ1-40 (1753.3 ± 253.4 pg/mg), which was abolished by Sch A treatment. Moreover, Sch A treatment repressed the proportions of iNOS+/Iba-1+ cells and IL-6 expression, while enhanced the proportions of Arg-1+/Iba-1+ cells and IL-10 expression in APP/PS1 mice. In vitro, Sch A treatment reduced the proportions of CD16/32+ cells, iNOS expression and IL-6 levels (25.7 ± 5.3 pg/mL) repressed M1 polarisation, and enhanced the proportions of CD206 cells, Arg-1 expression and IL-10 levels (75.9 ± 12.8 pg/mL) in BV2 cells.
CONCLUSIONS:
This research confirms the neuroprotective effect of Sch A in AD, suggesting that Sch A may become a potential anti-AD agent.
AuthorsQi Wang, Li Liu, Huibo Guan, Yanyan Zhou, Quan Li
JournalPharmaceutical biology (Pharm Biol) Vol. 59 Issue 1 Pg. 860-867 (Dec 2021) ISSN: 1744-5116 [Electronic] England
PMID34214019 (Publication Type: Journal Article)
Chemical References
  • Cyclooctanes
  • Lignans
  • Neuroprotective Agents
  • Polycyclic Compounds
  • schizandrin A
Topics
  • Alzheimer Disease (drug therapy, physiopathology)
  • Animals
  • Apoptosis (drug effects)
  • Brain (drug effects, physiopathology)
  • Cell Line
  • Cognition (drug effects)
  • Cyclooctanes (isolation & purification, pharmacology)
  • Disease Models, Animal
  • Lignans (isolation & purification, pharmacology)
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Mice, Transgenic
  • Microglia (drug effects, metabolism)
  • Neuroprotective Agents (isolation & purification, pharmacology)
  • Polycyclic Compounds (isolation & purification, pharmacology)
  • Schisandra (chemistry)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: